Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 196-202

  Chassin, Dorine ^a   Andrieu, Muriel ^a   Cohen, William ^a   Culmann Penciolelli, Béatrice ^a   Ostankovitch, Marina ^a   Hanau, Daniel ^a   Guillet, Jean Gérard ^a  

^a INSERM   (France)

Author keywords

Cytotoxic T lymphocyte; Dendritic cell; HIV 1; Nef; Transfection

Indexed keywords

NEF PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; BASE SEQUENCE; DENDRITIC CELLS; DNA PRIMERS; GENE PRODUCTS, NEF; GENES, NEF; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0032942068     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<196::AID-IMMU196>3.0.CO;2-4     Document Type: Article

References (28)

1. Hengel, H. and Koszinowski, U. H., Interference with antigen processing by viruses. Curr. Opin. Immunol. 1997. 9: 470-476.
2. Oldstone, M. B. A., How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players. Virology 1997. 234: 179-185.
3. McMichael, A. and Phillips, R., Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 1997. 15: 271-296.
4. Schwartz, O., Maréchal, V., Le Gall, S., Lemonnier, F. and Heard, J.-M., Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 1996. 2: 338-342.
5. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. and Trono, D., Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasm domain. Cell 1994. 76: 853-864.
6. Rossi, F., Evstaffieva, A., Pedrali-Noy, G., Gallina, A. and Milanesi, G., HsN3 proteasomal subunit as a target for human immunodeficiency virus type 1 Nef protein. Virology 1997. 237: 33-45.
7. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. and Baltimore, D., HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998. 391: 397-401.
8. Goulder, P., Price, D., Nowak, M., Rowland-Jones, S., Phillips, R. and McMichael, A., Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol. Rev. 1997. 159: 17-29.
9. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. and Oldstone, M., Virus specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994. 68: 6103-6110.
10. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655.
11. Lamhamedi-Cherradi, S., Culmann-Penciolelli, B., Guy, G., Kiény, M.-P., Dreyfus, F., Saimot, A., Sereni, D., Sicard, D., Levy, J. and Gomard, E., Qualitative and quantitative analysis of human cytotoxic T lymphocyte responses to HIV-1 proteins. AIDS 1992. 6: 1249-1258.
12. Bachmann, M. F., Lutz, M. B., Layton, G. T., Harris, S. J., Fehr, T., Rescigno, M. and Ricciardi-Castagnoli, P., Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 1996. 26: 2595-2600.
13. Reimann, J. and Kaufmann, S. H., Alternative antigen processing pathways in anti-infective immunity. Curr Opin. Immunol. 1997. 9: 462-469.
14. Boczkowski, D., Nair, S. K., Snyder, D. and Gilboa, E., Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 1996. 184: 465-472.
15. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K. and Falo, L. D. J., DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 1996. 2: 1122-1128.
16. Alijagic, S., Möller, P., Artuc, M., Jurgovsky, K., Czarnetzki, B. M. and Schadendorf, D., Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 1995. 25: 3100-3107.
17. Dupuis, M., Peshwa, M. V., Benike, C., Kundu, S. K., Engleman, E. G., Van Schooten, W. C. and Merigan, T. C., Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals. AIDS Res. Hum. Retroviruses 1997. 13: 33-39.
18. Yang, O. O., Kalams, S. A., Rosenzweig, M., Trocha, A., Jones, N., Koziel, M., Walker, B. and Johnson, R. P., Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 1996. 70: 5799-5806.
19. Couillin, I., Culmann-Penciolelli, B., Gomard, E., Choppin, J., Levy, J.-P., Guillet, J.-G. and Saragosti, S., Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 1994. 180: 1129-1134.
20. Couillin, I., Connan, F., Culmann-Penciolelli, B., Gomard, E., Guillet, J. G. and Choppin, J., HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding. Eur. J. Immunol. 1995. 25: 728-732.
21. Ossendorp, F., Eggers, M., Neisig, A., Ruppert, T., Groettrup, M., Sijts, A., Mengede, E., Kloetzel, P. M., Neefjes, J., Koszinowksi, U. and Melief, C., A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 1996. 5: 115-124.
22. Faradji, A., Bohbot, A., Schmitt-Goguel, M. et al., Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients. J. Immunol. Methods 1994. 174: 297-309.
23. Saudrais, C., Spehner, D., de la Salle, H., Bohbot, A., Cazenave, J. P., Goud, B., Hanau, O. and Salamero, J., Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. J. Immunol. 1998. 160: 2597-2607.
24. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
25. Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-Moiseiwitsch, F. and Swanstrom, R., Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 1993. 67: 4639-4650.
26. Koenig, S., Conley, A. J., Brewah, Y. A. et al., Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Med. 1995. 1: 330-336.
27. Coulie, P. G., Brichard, V., Van Pel, A. et al., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994. 180: 35-42.
28. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainhaut, P., Lemoine, C., Ohta, N., Old, L. and Boon, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992. 35: 145-152.